Hemostatic Comparison of a Polysaccharide Powder and a Gelatin Powder

REFERENCES

• Bracey A, Shander A, Aronson S, Boucher BA, Calcaterra D, Chu MWA, et al. The use of topical hemostatic agents in cardiothoracic surgery. Ann Thorac Surg. 2017;104(1):353–360. doi:10.1016/j.athoracsur.2017.01.096.
   PubMed Web of Science ®Google Scholar
• Wysham WZ, Roque DR, Soper JT. Use of topical hemostatic agents in gynecologic surgery. Obstet Gynecol Surv. 2014;69(9):557–563. doi:10.1097/OGX.0000000000000106.
   PubMed Web of Science ®Google Scholar
• Kommu SS, McArthur R, Emara AM, Reddy UD, Anderson CJ, Barber NJ, et al. Current status of hemostatic agents and sealants in urologic surgical practice. Rev Urol. 2015;17(3):150–159.
   PubMedGoogle Scholar
• Wright JD, Ananth CV, Lewin SN, Burke WM, Siddiq Z, Neugut AI, et al. Patterns of use of hemostatic agents in patients undergoing major surgery. J Surg Res. 2014;186(1):458–466. doi:10.1016/j.jss.2013.07.042.
   PubMed Web of Science ®Google Scholar
• Murat FJ, Ereth MH, Dong Y, Piedra MP, Gettman MT. Evaluation of microporous polysaccharide hemospheres as a novel hemostatic agent in open partial nephrectomy: Favorable experimental results in the porcine model. J Urol. 2004;172(3):1119–1122. doi:10.1097/01.ju.0000136001.99920.97.
   PubMed Web of Science ®Google Scholar
• Ereth MH, Henderson JL, Schrader LM, Nuttall GA, Oliver WC, editors. Efficacy of microporous polysaccharide hemospheres on liver punch biopsies in porcine model. The Anesthesiology Annual Meeting. San Francisco, CA: American Society of Anesthesiologists; 2003.
   Google Scholar
• Murat FJ, Le CQ, Ereth MH, Piedra MP, Dong Y, Gettman MT. Evaluation of microporous polysaccharide hemospheres for parenchymal hemostasis during laparoscopic partial nephrectomy in the porcine model. Jsls. 2006;10(3):302–306.
   PubMedGoogle Scholar
• Ersoy G, Kaynak MF, Yilmaz O, Rodoplu U, Maltepe F, Gokmen N. Hemostatic effects of microporous polysaccharide hemosphere in a rat model with severe femoral artery bleeding. Adv Ther. 2007;24(3):485–492. doi:10.1007/BF02848770.
   PubMed Web of Science ®Google Scholar
• Humphreys MR, Castle EP, Andrews PE, Gettman MT, Ereth MH. Microporous polysaccharide hemospheres for management of laparoscopic trocar injury to the spleen. Am J Surg. 2008;195(1):99–103. doi:10.1016/j.amjsurg.2007.03.006.
   PubMed Web of Science ®Google Scholar
• Ereth MH, Schaff M, Ericson EF, Wetjen NM, Nuttall GA, Oliver WC, Jr. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model. Neurosurgery. 2008;63(4 Suppl 2):369–372; discussion 72.
   PubMed Web of Science ®Google Scholar
• Bjorses K, Holst J. Topical haemostatics in renal trauma-an evaluation of four different substances in an experimental setting. J Trauma. 2009;66(3):602–11. doi:10.1097/TA.0b013e3181823533.
   PubMedGoogle Scholar
• Emmez H, Tonge M, Tokgoz N, Durdag E, Gonul I, Ceviker N. Radiological and histopathological comparison of microporous polysaccharide hemospheres and oxidized regenerated cellulose in the rabbit brain: A study of efficacy and safety. Turk Neurosurg. 2010;20(4):485–491.
   PubMed Web of Science ®Google Scholar
• Humphreys MR, Lingeman JE, Terry C, Castle EP, Andrews PE, Gettman MT, et al. Renal injury and the application of polysaccharide hemospheres: A laparoscopic experimental model. J Endourol. 2008;22(6):1375–1381. doi:10.1089/end.2008.0008.
   PubMed Web of Science ®Google Scholar
• Morse DC, Silva E, Bartrom J, Young K, Bass EJ, Potter D, et al. Improved bleeding scores using gelfoam((r)) powder with incremental concentrations of bovine thrombin in a swine liver lesion model. J Thromb Thrombolysis. 2016;42(3):352–359. doi:10.1007/s11239-016-1388-6.
   PubMed Web of Science ®Google Scholar
• Bruckner BA, Blau LN, Rodriguez L, Suarez EE, Ngo UQ, Reardon MJ, et al. Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures. J Cardiothorac Surg. 2014;9:134.brk doi:10.1186/s13019-014-0134-4.
   PubMed Web of Science ®Google Scholar
• Bochicchio GV, Gupta N, Porte RJ, Renkens KL, Pattyn P, Topal B, et al. The finish-3 trial: A phase 3, international, randomized, single-blind, controlled trial of topical fibrocaps in intraoperative surgical hemostasis. J Am Coll Surg. 2015;220(1):70–81. doi:10.1016/j.jamcollsurg.2014.09.019.
   PubMed Web of Science ®Google Scholar
• Verhoef C, Singla N, Moneta G, Muir W, Rijken A, Lockstadt H, et al. Fibrocaps for surgical hemostasis: Two randomized, controlled phase ii trials. J Surg Res. 2015;194(2):679–687. doi:10.1016/j.jss.2014.12.011.
   PubMed Web of Science ®Google Scholar
• Ruitenbeek K, Ayez N, Verhoef C, de Wilt JH, Bottema J, Rijken AM, et al. Safety and efficacy of a novel, dry powder fibrin sealant for hemostasis in hepatic resection. Dig Surg. 2014;31(6):422–427. doi:10.1159/000370006.
   PubMed Web of Science ®Google Scholar
• Gupta N, Chetter I, Hayes P, AH OY, Moneta GL, Shenoy S, et al. Randomized trial of a dry-powder, fibrin sealant in vascular procedures. J Vasc Surg. 2015;62(5):1288–1295. doi:10.1016/j.jvs.2015.05.038.
   PubMed Web of Science ®Google Scholar
• Schmitz C, Sodian R. Use of a plant-based polysaccharide hemostat for the treatment of sternal bleeding after median sternotomy. J Cardiothorac Surg. 2015;10:59. doi:10.1186/s13019-015-0263-4.
   PubMed Web of Science ®Google Scholar
• Antisdel JL, Janney CG, Long JP, Sindwani R. Hemostatic agent microporous polysaccharide hemospheres (mph) does not affect healing or intact sinus mucosa. Laryngoscope. 2008;118(7):1265–1269. doi:10.1097/MLG.0b013e31816c7bc9.
   PubMed Web of Science ®Google Scholar
• Schonauer C, Tessitore E, Barbagallo G, Albanese V, Moraci A. The use of local agents: Bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J. 2004;13(Suppl 1):S89–S96. doi:10.1007/s00586-004-0727-z.
   PubMed Web of Science ®Google Scholar
• Lewis KM, Atlee HD, Mannone AJ, Dwyer J, Lin L, Goppelt A, et al. Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model. J Invest Surg. 2013;26(3):141–148. doi:10.3109/08941939.2012.724519.
   PubMed Web of Science ®Google Scholar
• Oz MC, Cosgrove DM, 3rd, Badduke BR, Hill JD, Flannery MR, Palumbo R, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The fusion matrix study group. Ann Thorac Surg. 2000;69(5):1376–1382. doi:10.1016/S0003-4975(00)01194-2.
   PubMed Web of Science ®Google Scholar
• Council NR. Guide for the Care and Use of Laboratory Animals: Eighth Edition. Washington, DC: The National Academies Press; 2011. 246 p.
   Google Scholar
• Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147–156. doi:10.1056/NEJMra1011170.
   PubMed Web of Science ®Google Scholar
• Jalal DI, Chonchol M, Targher G. Disorders of hemostasis associated with chronic kidney disease. Semin Thromb Hemost. 2010;36(1):34–40. doi:10.1055/s-0030-1248722.
   PubMed Web of Science ®Google Scholar
• Mabry CD, Thompson BW, Read RC. Activated clotting time (act) monitoring of intraoperative heparinization in peripheral vascular surgery. Am J Surg. 1979;138(6):894–900. doi:10.1016/0002-9610(79)90318-0.
   PubMed Web of Science ®Google Scholar
• Adams GL, Manson RJ, Hasselblad V, Shaw LK, Lawson JH. Acute in-vivo evaluation of bleeding with gelfoam plus saline and gelfoam plus human thrombin using a liver square lesion model in swine. J Thromb Thrombolysis. 2009;28(1):1–5. doi:10.1007/s11239-008-0249-3.
   PubMed Web of Science ®Google Scholar
• Lewis KM, Li Q, Jones DS, Corrales JD, Du H, Spiess PE, et al. Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents. Surgery. 2017;161(3):771–781. doi:10.1016/j.surg.2016.09.022.
   PubMed Web of Science ®Google Scholar
• Team RC. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2017.
   Google Scholar
• Therneau TM. A Package for Survival Analysis in s. R package version 2.38. Vienna, Austria: R Foundation for Statistical Computing; 2015.
   Google Scholar
• Winters KJ, Walsh JJ, Rubin BG, Santoro SA. Platelet interactions with fibronectin: Divalent cation-independent platelet adhesion to the gelatin-binding domain of fibronectin. Blood. 1993;81(7):1778–1786.
   PubMed Web of Science ®Google Scholar
• Xu J, Mosher D. Fibronectin and other adhesive glycoproteins. In: Mecham R, editor. The Extracellular Matrix: An Overview. Berlin, Springer Science & Business Media; 2011. pp. 41–75.
   Google Scholar
• Engvall E, Ruoslahti E, Miller EJ. Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med. 1978;147(6):1584–1595. doi:10.1084/jem.147.6.1584.
   PubMed Web of Science ®Google Scholar
• MacDonald MH, Wang AY, Clymer JW, Hutchinson RW, Kocharian R. An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models. Med Devices (Auckl). 2017;10(1):273–279.
   PubMedGoogle Scholar